These medications are designed to treat obesity as a long-term disease, said Ali
A landmark trial published in the New England Journal of Medicine found that participants using tirzepatide lost up to 20.9% of their body weight over 72 weeks, with results improving at higher doses across all treatment groups (Jastreboff et al., NEJM, 2022, North Carolina residents across the state, from Asheville to Wilmington, have real, practical access to tirzepatide today
A low-and-slow approach to dosing is widely recommended to minimize side effects
Luckily, some financial freedom may be on the horizon
Compounded versions are increasingly restricted but may still be available in specific clinical situations
Those patients may only need a total dose of two 8 milligram tablets each day